Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Collaborative research between the Universities of Dundee and Cambridge has uncovered how ‘assassin’ immune cells are able keep on killing as they hunt down cancer cells, repeatedly reloading their toxic weapons.
News
Vivien Shek, a second year PhD student, has been awarded a Royal Society of Edinburgh Saltire Early Career Fellowship.
Press release
A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
News
Gabriel Sollberger has been awarded funding from the Springboard scheme of the Academy of Medical Sciences, which is designed to help early career researchers establish their independent research programmes.
News
Collaborative research between scientists in the Division of Cell Signalling and Immunology and the University of Leeds has been published in eLife.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.